ECSP992970A - Secuencia del gen relacionado con angiopoyetino scarface 3 - Google Patents

Secuencia del gen relacionado con angiopoyetino scarface 3

Info

Publication number
ECSP992970A
ECSP992970A ECSP992970A ECSP992970A EC SP992970 A ECSP992970 A EC SP992970A EC SP992970 A ECSP992970 A EC SP992970A EC SP992970 A ECSP992970 A EC SP992970A
Authority
EC
Ecuador
Prior art keywords
scarface
proteins
angiopoyetino
sequence
gene related
Prior art date
Application number
Other languages
English (en)
Inventor
Paul Robert Rosteck
Stanley Gene Burgett
Josef Georg Heuer
Rebecca Ann Leonard
Patanjali Raghavac Sankhavaram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP992970 priority Critical patent/ECSP992970A/es
Publication of ECSP992970A publication Critical patent/ECSP992970A/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invención proporciona compuestos de ácido nucleico, de scarface 3, sus proteínas y fragmentos aislados, estando dichas proteínas Scarface 3 relacionadas con la familia de la angiopoyetina. También se proporcionan vectores y células huésped heterólogas transformadas para expresar Scarface 3, procedimientos para la identificación de compuestos que se unen a, y/o modulan la actividad de, dichas proteínas Scarface 3, además de procedimientos para tratar cáncer y la mielosupresión, y composiciones farmacéuticas que comprenden Scarface 3 o sus análogos.
ECSP992970 1999-06-01 1999-06-01 Secuencia del gen relacionado con angiopoyetino scarface 3 ECSP992970A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP992970 ECSP992970A (es) 1999-06-01 1999-06-01 Secuencia del gen relacionado con angiopoyetino scarface 3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP992970 ECSP992970A (es) 1999-06-01 1999-06-01 Secuencia del gen relacionado con angiopoyetino scarface 3

Publications (1)

Publication Number Publication Date
ECSP992970A true ECSP992970A (es) 2000-01-27

Family

ID=42043959

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP992970 ECSP992970A (es) 1999-06-01 1999-06-01 Secuencia del gen relacionado con angiopoyetino scarface 3

Country Status (1)

Country Link
EC (1) ECSP992970A (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9695233B2 (en) 2012-07-13 2017-07-04 Roche Glycart Ag Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
US12503503B2 (en) 2018-10-29 2025-12-23 Hoffmann-La Roche Inc. Bispecific anti-VEGF/ANG2 antibody formulation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9695233B2 (en) 2012-07-13 2017-07-04 Roche Glycart Ag Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
US12503503B2 (en) 2018-10-29 2025-12-23 Hoffmann-La Roche Inc. Bispecific anti-VEGF/ANG2 antibody formulation

Similar Documents

Publication Publication Date Title
JOP20220079A1 (ar) بروتين ربط متعددة الخصوصية لمعالجة السرطان
BR112021022874A2 (pt) Proteínas de ligação epcam e métodos de uso
BR9711795A (pt) Peptìdeos tendo propriedades antiproliferativas
MX2020009514A (es) Anticuerpos anti-claudina 18.2 (cldn18.2).
AR053063A2 (es) Proteina sustancialmente purificada y composicion farmaceutica que la comprende
ES2096750T3 (es) Vectores retroviricos utiles para la terapia genica.
FR17C1046I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
BR0316435A (pt) Produtos genéticos expressos diferencialmente em tumores e uso dos mesmos
DK1103564T3 (da) Cancerantigener baseret på tumorsuppressorgen WT1-produkt
BR112022012327A2 (pt) Anticorpos ou fragmentos dos mesmos, ácido nucleico, vetor e célula hospedeira
WO2004053079A3 (en) Compositions, splice variants and methods relating to ovarian specific genes and proteins
TR199902053T2 (xx) Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar.
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
BR0015137A (pt) Peptìdeos antigênicos de neisseria
ATE300619T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
ATE473283T1 (de) Dna-expressionsvektoren
EP0962530A3 (en) Gene sequence encoding for the angiopoietin related protein scarface 1
BR9712575A (pt) Processo para restaurar em células que apresentam uma proteìna p53 que sofreu mutação , uma atividade de transactivação p53-dependente, utilizações de um anticorpo de cadeia simples capaz de ligar especificamente uma proteìna p53 que sofreu mutação, e de um ácido nucleico codificante, molécula 11d3 ou uma variante, ácido nucleico e composição
SV1999000069A (es) Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261
SE0301987D0 (sv) New polypeptide
DE59712554D1 (de) Rekombinante expression von s-layer-proteinen
ZA202310639B (en) Interleukin 15 variants
BR9915513A (pt) Interagentes de canal de potássio e usos para tais
DE69733491D1 (de) In Krebszellen überexprimiertes Genprodukt
DE60137222D1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc-2